Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
Kezar Life Sciences Free Cash Flow : -42.03M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -42.03M |
| December 31, 2025 | -51.78M |
| September 30, 2025 | -56.66M |
| June 30, 2025 | -64.34M |
| March 31, 2025 | -68.58M |
| December 31, 2024 | -74.24M |
| September 30, 2024 | -76.39M |
| June 30, 2024 | -79.22M |
| March 31, 2024 | -85.16M |
| December 31, 2023 | -83.46M |
| September 30, 2023 | -80.70M |
| June 30, 2023 | -77.32M |
| March 31, 2023 | -67.82M |
| December 31, 2022 | -60.42M |
| September 30, 2022 | -55.54M |
| June 30, 2022 | -48.56M |
| March 31, 2022 | -48.16M |
| Date | Value |
|---|---|
| December 31, 2021 | -42.75M |
| September 30, 2021 | -40.80M |
| June 30, 2021 | -40.07M |
| March 31, 2021 | -37.11M |
| December 31, 2020 | -37.14M |
| September 30, 2020 | -34.98M |
| June 30, 2020 | -34.05M |
| March 31, 2020 | -32.14M |
| December 31, 2019 | -30.48M |
| September 30, 2019 | -28.85M |
| June 30, 2019 | -25.22M |
| March 31, 2019 | -24.68M |
| December 31, 2018 | -21.91M |
| September 30, 2018 | -18.00M |
| June 30, 2018 | -15.81M |
| March 31, 2018 | -10.45M |
| December 31, 2017 | -8.498M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| NovelStem International Corp. | -0.2295M |
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -458.40M |
| Protara Therapeutics, Inc. | -66.49M |
| Clene, Inc. | -16.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.445M |
| Cash from Investing (Quarterly) | 1.529M |
| Cash from Financing (Quarterly) | 0.267M |
| Free Cash Flow Per Share (Quarterly) | -1.014 |
| Free Cash Flow to Equity (Quarterly) | -6.473M |
| Free Cash Flow to Firm (Quarterly) | -7.445M |
| Free Cash Flow Yield | -78.70% |